Comparison of Two Manufacturing Processes of Daprodustat for Bioequivalence and Dissolution in Healthy Volunteers: A Randomized Crossover Study.

导出 LinkOut

翻译打印收藏纠错

作者： Bonnie,Shaddinger ^[1] ; Kelly M,Mahar ^[1] ; Mike,Sprys ^[1] ; Susan M,Andrews ^[2] ; Sayantan,Chattoraj ^[1] ; Rubeen,Israni ^[1] ; Alex,Cobitz ^[1]

作者单位： GSK, Collegeville, Pennsylvania, USA. ^[1] Global Clinical Operations Development R&D, GSK, Research Triangle Park, Durham, North Carolina, USA. ^[2]

关键词 anemia bioequivalence chronic kidney disease daprodustat high-shear wet granulation twin-screw granulation

主题词人类(Humans);治疗等效(Therapeutic Equivalency);交叉研究(Cross-Over Studies);溶解度(Solubility);片剂(Tablets)

DOI 10.1002/cpdd.1257

PMID 37125459

发布时间 2024-04-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical pharmacology in drug development

2023年12卷7期

739-748页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Comparison of Two Manufacturing Processes of Daprodustat for Bioequivalence and Dissolution in Healthy Volunteers: A Randomized Crossover Study.

Clinical pharmacology in drug development

相似文献

Clinical pharmacology in drug development

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparison of Two Manufacturing Processes of Daprodustat for Bioequivalence and Dissolution in Healthy Volunteers: A Randomized Crossover Study.

Clinical pharmacology in drug development

相似文献

Clinical pharmacology in drug development

相关期刊

检索历史清除